top of page
Access for Life will solve the clinical challenge for patients with chronic disease, that require repetitive vein access with dialysis as our first market. The patented subcutaneously implanted, sensor-enhanced SEAL device preserves vein health while reducing the risk of clinical complications caused by damage to the vessel walls. It provides real-time data collection during hemodialysis. The device provides easy and safe cannulation, enabling patients to self-cannulate at home encouraging home hemodialysis or in the clinic.
JEM Mount Sinai  2021-09-02.png
bottom of page